R01 HL-43151/HL/NHLBI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1995	3
1996	3
1997	9
1998	6
1999	11
2000	5
2001	6
2002	9
2003	3
2004	2
2021	0

1

The nitric oxide hypothesis of late preconditioning.

Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J. Bolli R, et al. Basic Res Cardiol. 1998 Oct;93(5):325-38. doi: 10.1007/s003950050101. Basic Res Cardiol. 1998. PMID: 9833145 Free PMC article. Review.

2

Role of nitric oxide in myocardial preconditioning.

Dawn B, Bolli R. Dawn B, et al. Ann N Y Acad Sci. 2002 May;962:18-41. doi: 10.1111/j.1749-6632.2002.tb04053.x. Ann N Y Acad Sci. 2002. PMID: 12076960 Review.

3

Emerging role of the JAK-STAT pathway as a mechanism of protection against ischemia/reperfusion injury.

Bolli R, Dawn B, Xuan YT. Bolli R, et al. J Mol Cell Cardiol. 2001 Nov;33(11):1893-6. doi: 10.1006/jmcc.2001.1469. J Mol Cell Cardiol. 2001. PMID: 11708835 No abstract available.

4

The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview.

Bolli R. Bolli R. Basic Res Cardiol. 1996 Jan-Feb;91(1):57-63. doi: 10.1007/BF00788866. Basic Res Cardiol. 1996. PMID: 8660262 Review. No abstract available.

5

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, Dawn B. Bolli R, et al. Cardiovasc Res. 2002 Aug 15;55(3):506-19. doi: 10.1016/s0008-6363(02)00414-5. Cardiovasc Res. 2002. PMID: 12160947 Free PMC article. Review.

6

Common methodological problems and artifacts associated with studies of myocardial stunning in vivo.

Bolli R. Bolli R. Basic Res Cardiol. 1995 Jul-Aug;90(4):257-62. doi: 10.1007/BF00797893. Basic Res Cardiol. 1995. PMID: 8534240 Review. No abstract available.

7

Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.

Bolli R. Bolli R. J Mol Cell Cardiol. 2001 Nov;33(11):1897-918. doi: 10.1006/jmcc.2001.1462. J Mol Cell Cardiol. 2001. PMID: 11708836 Review.

8

Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.

Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R. Leesar MA, et al. J Am Coll Cardiol. 1999 Sep;34(3):639-50. doi: 10.1016/s0735-1097(99)00297-1. J Am Coll Cardiol. 1999. PMID: 10483942 Free article. Clinical Trial.

9

Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction.

Dawn B, Takano H, Tang XL, Kodani E, Banerjee S, Rezazadeh A, Qiu Y, Bolli R. Dawn B, et al. Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H549-56. doi: 10.1152/ajpheart.00873.2001. Am J Physiol Heart Circ Physiol. 2002. PMID: 12124200 Free article.

10

Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.

Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R. Wang Y, et al. J Mol Cell Cardiol. 2002 Jan;34(1):5-15. doi: 10.1006/jmcc.2001.1482. J Mol Cell Cardiol. 2002. PMID: 11812160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results